Polypharmacy in Psychiatry Practice, Volume I

<p>About the Editor</p><p>Preface  </p><p>Contributors</p><p>Part I. Polypharmacy treatment strategies </p><p>1. Multiple medication use in psychiatry: How Rational Can It Be? Ahsan Khan and Sheldon Preskorn<p>2. Receptor binding targets for antipsychotic efficacy; Maureen M. Grainger, Rebecca Ahlbrand, Paul S. Horn, Neil M. Richtand</p><p>3. Drug interactions and polypharmacy; Jessica L. Gören, and Ashley Tewksbury<p>4. Preclinical and clinical investigation of antipsychotic polypharmacy: What is the evidence? Dimitrios Kontis, Eirini Theochari</p><p>5. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy? Stephen M. Stahl and Debbi A. Morrissette</p><p>6. Multiple Medication Use of Neuropsychiatry in Forensic Psychiatry: Findings from the Central State Forensic Psychiatric Hospital of Saxony-Anhalt; Joachim G. Witzel<p><p>Part II. Augmentation strategies</p><p>7. Antipsychotic treatment within a naturalistic trial - how are we treating schizophrenia patients in the "real-world"? Rebecca Schennach, Michael Obermeier, Florian Seemüller, Daniela Krause, Richard Musil, Ilja Spellmann, Hans-Jürgen Möller, Michael Riedel <p>8. A multi-target drug treatment in schizophrenia using adjunctive agents with non-D₂ mechanisms of action; Michael S Ritsner<p>9. Antidepressants in schizophrenia – a place for them? Viacheslav Terevnikov and Grigori Joffe<p>10.  Stressful life events and anticonvulsant medication in psychiatric patients; Petr Bob<p>11.  Multiple medication use in somatic symptom disorders: from augmentation to diminution strategies; Adrian P. Mundt<p>Appendix; Rena Kurs<p>Annotated bibliography on polypharmacy</p><p>List of Psychotropic Medications  </p><p>Contents to Volume II <p>Contributors to Volume II</p><p>Index</p>